Cystic Fibrosis: all 1,605 studies
Page 13 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- High Volumes of Hypertonic Saline and Chest Physiotherapy in CF PatientsCompletedNCT01943890Not applicable
- CPET in CF Patients With One G551D Mutation Taking VX770Status unknownNCT01937325Phase 4
- Johns Hopkins Breast Cancer Program Longitudinal RepositoryActive, not recruitingNCT01937039
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic FibrosisTerminatedNCT01923753Phase 2
- Autologous CD117+ Progenitor Cell Mobilization for Lung TransplantationCompletedNCT01916577Phase 1
- Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic FibrosisCompletedNCT01915875Not applicable
- Phase 1, QT/QTC Interval Study in Healthy SubjectsCompletedNCT01910415Phase 1
- A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With IvacaftorCompletedNCT01899105Phase 1
- INSPIRE-CF: an Alternative Physiotherapy Model for Children With Cystic FibrosisCompletedNCT01889927Not applicable
- Repeatability and Response Study of Absorptive Clearance ScansCompletedNCT01887197Phase 1
- The Addition of Non-Invasive Ventilation To Airway Clearance Techniques In Adults With Cystic FibrosisTerminatedNCT01885650Not applicable
- LAIV (Flumist®) Administration in CF PatientsStatus unknownNCT01885169
- Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 YearsCompletedNCT01883531Phase 2
- Action of Epigenetic Modifiers in Cystic Fibrosis TreatmentCompletedNCT01883284Not applicable
- Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RTCompletedNCT01883037
- Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular DystrophyCompletedNCT01882400Phase 4
- Comparison of Absorption of Vitamin D in Cystic FibrosisCompletedNCT01880346Phase 4
- Near Patient Microbial Testing in Cystic FibrosisCompletedNCT01877707Not applicable
- An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic FibrosisCompletedNCT01863238
- Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)CompletedNCT01860872
- Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement TherapyCompletedNCT01858519
- Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.CompletedNCT01848392
- Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CFCompletedNCT01840735Phase 1
- Quantitative Computed Tomodensitometry in Patients With Cystic FibrosisCompletedNCT01837589Not applicable
- Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic FibrosisTerminatedNCT01837355Not applicable
- Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CFCompletedNCT01832519
- Bacteriophage Effects on Pseudomonas AeruginosaCompletedNCT01818206Not applicable
- Cough-Generated Aerosols of NTM in Cystic FibrosisCompletedNCT01815866
- Treatment of Low Bone Density in Cystic Fibrosis.CompletedNCT01812551Phase 3
- High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled StudyTerminatedNCT01810536Not applicable
- Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis PatientsCompletedNCT01806025
- Biomarkers of Injury and Destruction in the Cystic Fibrosis LungCompletedNCT01805713
- Evaluating Sensations of Breathlessness in Patients With Cystic FibrosisCompletedNCT01799642
- A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy SubjectsTerminatedNCT01793649Phase 1
- Bone Microarchitecture in Young Cystic Fibrosis PatientsCompletedNCT01788267Not applicable
- Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic FibrosisCompletedNCT01783613Not applicable
- A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult SubjectsCompletedNCT01768663Phase 1
- Comprehensive Exercise Training Program During Hospitalization for an Acute CF ExacerbationCompletedNCT01759342Not applicable
- Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic FibrosisTerminatedNCT01753869Not applicable
- Effects of a Partially Supervised Conditioning Program in CFCompletedNCT01744561Not applicable
- Effect of Lactobacillus Reuteri in Cystic FibrosisCompletedNCT01737983Phase 4
- Time to Perform Lung Function Test in Cystic FibrosisCompletedNCT01737801Not applicable
- Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine SolutionCompletedNCT01736839
- Imaging Lung Function Using Oxygen Enhanced MRICompletedNCT01731015Phase 1
- The Effects of Massage Therapy on QOL in Youth/Young Adults With Cystic FibrosisCompletedNCT01729585Not applicable
- Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic FibrosisCompletedNCT01721382Phase 1
- Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedNCT01710644Phase 1/2
- Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With OxygenCompletedNCT01710449Phase 1
- Sweat Evaporimeter MeasurementCompletedNCT01708655Not applicable
- Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic FibrosisCompletedNCT01706445Not applicable
- Zoledronic Acid in Cystic FibrosisWithdrawnNCT01702415Phase 4
- Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic TreatmentCompletedNCT01695343Phase 2
- Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic FibrosisCompletedNCT01693965Not applicable
- Web-based Delivery of Effective Treatment for Growth in Cystic FibrosisCompletedNCT01686672Not applicable
- A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic FibrosisStatus unknownNCT01667094Phase 4
- Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic FibrosisCompletedNCT01661491
- Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis PatientsCompletedNCT01658449Not applicable
- Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)TerminatedNCT01652157
- Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000CompletedNCT01651455
- Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.CompletedNCT01641393Phase 3
- Cough Efficiency in Cystic FibrosisCompletedNCT01636219
- A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)CompletedNCT01626157
- Repeated Application of Gene Therapy in CF PatientsCompletedNCT01621867Phase 2
- Preventive Inhalation of Hypertonic Saline in Infants With Cystic FibrosisCompletedNCT01619657Phase 2
- The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic FibrosisCompletedNCT01616862
- Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic FibrosisCompletedNCT01608555Phase 4
- Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants with Cystic FibrosisCompletedNCT01605565Not applicable
- Social Cognition in Children Treated for a Brain TumourCompletedNCT01599052
- Oxygen Therapy in Cystic FibrosisTerminatedNCT01586728Not applicable
- ATCF (Azole Therapy in Cystic Fibrosis)CompletedNCT01576315Phase 2
- Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF PatientsCompletedNCT01572870
- Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)TerminatedNCT01572194Not applicable
- Pre-flight Evaluation of Adult Patients With Cystic FibrosisCompletedNCT01569880
- Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic FibrosisCompletedNCT01548729Phase 1/2
- The Use of Visual Feedback in Airway ClearanceCompletedNCT01546779Not applicable
- Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic FibrosisStatus unknownNCT01543620
- A Safety and Tolerability Study OF PUR118 In Subjects With Cystic FibrosisCompletedNCT01543191Phase 1
- Pharmacokinetic Study of Aerosolized Colimycin in Cystic FibrosisCompletedNCT01537614Phase 1
- CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic TreatmentCompletedNCT01533636
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)CompletedNCT01521338
- Pharmacokinetics of Vancomycin for Inhalation in Cystic FibrosisWithdrawnNCT01509339Phase 1
- Self Drainage in Pediatric Cystic Fibrosis PatientsCompletedNCT01509235Not applicable
- Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza VaccinationCompletedNCT01499914Phase 4
- Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and FunctionCompletedNCT01494909Not applicable
- Clinical Evaluation of NeoPlex4 Assay and NeoPlex SystemCompletedNCT01488721
- Bronchial Inflammation of Small Airways in Patients With Cystic FibrosisCompletedNCT01479166
- Small Intestinal Function in Patients With Cystic FibrosisStatus unknownNCT01468428
- A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. FibrosisCompletedNCT01465529Phase 1/2
- Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study CentersWithdrawnNCT01460849
- Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic FibrosisCompletedNCT01460836
- Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis PatientsCompletedNCT01455675Phase 3
- Inhaled Glutathione (GSH) Versus Placebo in Cystic FibrosisStatus unknownNCT01450267Phase 3
- Exocrine Pancreatic Function Testing in Cystic FibrosisStatus unknownNCT01446861
- Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)CompletedNCT01426256Phase 3
- Baby Observational and Nutritional StudyCompletedNCT01424696
- Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic FibrosisCompletedNCT01401439
- Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic FibrosisCompletedNCT01400750Phase 4
- VX-770 Expanded Access ProgramApproved for marketingNCT01381289
- Volatile Organic Compounds in Cystic FibrosisCompletedNCT01379040